NEW YORK STATE OFFICE OF MENTA has a total of 13 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are FEMALON S P R L, ALKON DANIEL L and FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIV RAMON Y CAJAL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Enzymes | |
#4 | Measuring microorganism processes | |
#5 | Microorganisms | |
#6 | Unspecified technologies | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Richardson Mary Ann | 10 |
#2 | Mathews Paul M | 2 |
#3 | Schmidt Stephen D | 2 |
#4 | Jiang Ying | 2 |
#5 | Nixon Ralph A | 2 |
#6 | Duff Karen | 1 |
#7 | Matsuoka Yasuji | 1 |
Publication | Filing date | Title |
---|---|---|
AU2002366355A1 | SEQUESTRATION OF ABeta IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES | |
EP1421198A2 | Cell-based high-throughput screening methods | |
US6200758B1 | Phenylalanine hydroxylase gene variants, and amino acid and pterin homeostasis, in the definition, detection, treatment and prevention of psychotic, mood and personality disorders | |
US5670539A | Treatment of movement disorders using large neutral amino acids | |
US5393784A | Treatment of tardive dyskinesia with leucine, isoleucine, valine or mixtures thereof |